Murdoch-based Orthocell’s push to expand the reach of its nerve repair product Remplir has continued, following news it has received regulatory approval in Hong Kong.
Orthocell boss Paul Anderson said the Murdoch-based biotech medical company is “well ahead” of its original targets in relation to US sales of its nerve repair product, Remplir.
FBR shareholders have overwhelmingly endorsed all three resolutions at the company’s extraordinary general meeting on Tuesday, following a late push to have it deferred.
DUG Technology managing director Matthew Lamont is excited by the company’s future, as it continues to move forward with its elastic MP-FWI imaging technology.
Shares in Murdoch-based Orthocell rose by 15 per cent early on Wednesday, following news the biotech medical company had received regulatory approval to sell its nerve repair product in Canada.
Fresh from receiving clearance from the Food and Drug Administration to distribute its nerve repair product Remplir in the US earlier this month, Murdoch-based Orthocell has appointed an initial four distributors.
Perth-based Track'em, which counts some of WA’s largest resources companies as clients, has struck a partnership with UK-based industrial software giant AVEVA.
Pentanet may have kept up the earnings momentum this quarter, but investors appear unimpressed as the telco’s shares took another tumble on Wednesday morning.
Vince Ippolito chaired Botanix will ask investors for $40 million as it eyes an expansion of its US offerings following a successful first few months in the market.
Orthocell has posted its fourth consecutive quarter of record revenue, as the regenerative medicine company continues to expand its reach around the globe.
High Wycombe-based FBR has made a series of cost-cutting changes to its board, including the retirement of chief executive and managing director Mike Pivac.
The reliability of the US as a security partner and the evolving threat of foreign interference were central themes of Business News’ Sector Briefing: Security and Resilience.
Subiaco-based biotech business Holista CollTech has sued a US company in the Supreme Court of WA over alleged misleading and deceptive representations.
Nine Entertainment has confirmed the personal data up to 16,000 subscribers to The Age, The Australian Financial Review and The Sydney Morning Herald have been exposed online.